Multicenter Comparison of Novel Self-Expanding Versus Balloon-Expandable Transcatheter Heart Valves
作者: Oliver HusserWon-Keun KimCostanza PellegriniAndreas HolzamerThomas WaltherPatrick N. MayrMichael JonerAlbert M. KaselTeresa TrenkwalderJonathan MichelTobias RheudeAdnan KastratiHeribert SchunkertChristof BurgdorfMichael HilkerHelge MöllmannChristian Hengstenberg
作者单位: 1Klinik für Herz und Kreislauferkrankungen, Deutsches Herzzentrum München, Technical University Munich, Munich, Germany
2Department of Cardiology, Kerckhoff Heart and Lung Center, Bad Nauheim, Germany
3Klinik für Herz, Thorax, und Herznahe Gefäßchirurgie, University of Regensburg Medical Center, Regensburg, Germany
4Department of Cardiovascular Surgery, Kerckhoff Heart and Lung Center, Bad Nauheim, Germany
5Institut für Anästhesiologie, Deutsches Herzzentrum München, Technical University Munich, Munich, Germany
6Deutsches Zentrum für Herz- und Kreislauf-Forschung (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
7Herz und Gefäßzentrum Bad Bevensen, Klinik für Kardiologie, Bad Bevensen, Germany
刊名: JACC: Cardiovascular Interventions, 2017
来源数据库: Elsevier Journal
DOI: 10.1016/j.jcin.2017.06.026
关键词: ACURATE neoSAPIEN 3transcatheter aortic valve replacementVARC-2
英文摘要: Abstract(#br)Objectives(#br)This study sought to compare 2 next-generation transcatheter heart valves (THV), the self-expanding ACURATE neo (NEO) and the balloon-expandable SAPIEN 3 (S3), in terms of device failure and early safety at 30 days.(#br)Background(#br)Deployment of these THV showed promising initial clinical results. However, no comparative data are available.(#br)Methods(#br)Of 1,121 treated patients at 3 centers, a 1-to-2 nearest neighbor matching was performed to identify 2 patients treated with S3 (n = 622) for each patient treated with NEO (n = 311).(#br)Results(#br)In-hospital complications were comparable between NEO and S3, including stroke (1.9% vs. 2.4%; p = 0.64), major vascular complications (10.3% vs. 8.5%; p = 0.38), or life-threatening bleeding (4.2% vs. 3.7%; p...
全文获取路径: Elsevier  (合作)
分享到:
来源刊物:
影响因子:6.552 (2012)

×